Skip to main content
. 2012 May 1;6(3):581–588. doi: 10.1177/193229681200600313

Table 4.

Differences in Glycated Hemoglobin in Diabetes Patients with Insulin

Baseline HbA1c % (SD) End of the trial HbA1c % (SD) Difference intragroup
Intervention 7.88 (1.38) 7.19 (0.93) −0.69, p = .001

Control 7.80 (1.52) 7.71 (1.37) −0.09, p not significanta

Difference between groups −0.08, p not significantb −0.52, p = .01
a

Not significant, intragroup comparison

b

Not significant, comparison between groups.